Health Cor Management, L.P. Aurinia Pharmaceuticals Inc. Transaction History

Health Cor Management, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$10.0 - $14.52 $9.5 Million - $13.8 Million	-950,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$12.3 - $18.73 $73.6 Million - $112 Million	-5,987,448 Reduced 86.31%	950,000 $12.3 Million
Q4 2020 Feb 16, 2021	SELL	$12.94 - $16.05 $25.1 Million - $31.1 Million	-1,936,505 Reduced 21.82%	6,937,448 $95.9 Million
Q3 2020 Nov 16, 2020	SELL	$13.19 - $16.66 $8.28 Million - $10.5 Million	-627,445 Reduced 6.6%	8,873,953 $131 Million
Q2 2020 Aug 14, 2020	SELL	$14.12 - $18.33 $3.71 Million - $4.81 Million	-262,522 Reduced 2.69%	9,501,398 $154 Million
Q1 2020 May 15, 2020	BUY	$11.34 - $21.46 $56.1 Million - $106 Million	4,943,590 Added 102.56%	9,763,920 $142 Million
Q4 2019 Feb 14, 2020	BUY	$3.88 - $21.42 $15.5 Million - $85.4 Million	3,987,960 Added 479.11%	4,820,330 $97.7 Million
Q3 2019 Nov 14, 2019	BUY	$5.34 - $6.59 $4.44 Million - $5.49 Million	832,370 New	832,370 $4.45 Million

207

58.6M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.28B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.